Fieber und wechselnde Diagnosen – was macht den Fünfjährigen so krank?

• Literatur

• 1 Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16 (03) 178-222.
• 2 Ozen S. et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936-941.
• 3 Park AH. et al. Patterns of Kawasaki syndrome presentation. Int J Pediatr Otorhinolaryngol 1997; 40 (01) 41-50.
• 4 Burns JC. et al. Infliximab treatment of intravenous immunglobulin-resistant Kawasaki disease. Journal of Pediatr 2008; 153 (06) 833-838.
• 5 Raman V. et al. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatr Infect Dis J 2001; 20 (06) 635-637.
• 6 Kuijpers TW. et al. Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect. Pediatrics 2003; 112 (04) 986-992.
• 7 Newburger JW. et al. Diagnosis, treatment and longterm management of Kawasaki disease: a statement for health professionals from the committee on Rheumatic Fever, Endocarditis and Kawasaki Disease. Council on Cardiovascular Disease in the Young. American Heart Association. Circulation 2004; 110 (17) 2747-2771.